Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Prostatic Neoplasms 8Breast Neoplasms 8Neoplasms 7Depression 6Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasm Metastasis 3Multiple Myeloma 3Lymphoma, Mantle-Cell 3Lymphoma 3Leukemia, Lymphocytic, Chronic, B-Cell 3Head and Neck Neoplasms 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Anxiety Disorders 3Triple Negative Breast Neoplasms 2Thyroid Neoplasms 2Prostatic Hyperplasia 2Myeloproliferative Disorders 2Myelodysplastic Syndromes 2Melanoma 2Lymphoma, Non-Hodgkin 2Lymphoma, B-Cell, Marginal Zone 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Kidney Neoplasms 2Fatigue 2

Interventions

Cyclophosphamide 16Mycophenolic Acid 13Tacrolimus 10fludarabine 9ruxolitinib 8Busulfan 7fludarabine phosphate 6Whole-Body Irradiation 6Sirolimus 6Melphalan 6Methotrexate 5Thiotepa 4ibrutinib 3Specimen Handling 3Cyclosporine 3Abatacept 3Stem Cell Transplantation 2Radiotherapy 2Hematopoietic Stem Cell Transplantation 2Clofarabine 2Biopsy 2vedolizumab 1tildrakizumab 1itacitinib 1blinatumomab 1belumosudil 1axatilimab 1Vorinostat 1Therapeutics 1Rituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Graft vs Host Disease × Therapeutics × 1 year × Clear all
NCT05655546 2025-08-08

ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals

Scripps Translational Science Institute

Phase NA Terminated
2,117 enrolled 6 charts
LymphoidOther hematologic neoplasmPlasma cell

COVID-19, Graft vs Host Disease, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Multiple Myeloma, Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡